Copper (64Cu) Chloride

Copper (64Cu) Chloride is an innovative compound being studied in clinical trials for various medical conditions. This article explores its use in two distinct areas: as part of a gene therapy approach for Wilson’s Disease and as a diagnostic tool for neuroendocrine tumors. These trials showcase the versatility of Copper (64Cu) Chloride in both treatment and imaging applications, potentially offering new hope for patients with these challenging conditions.

Table of Contents

What is COPPER (64CU) CHLORIDE?

COPPER (64CU) CHLORIDE is a radioactive form of copper used in medical imaging. It’s also known by other names such as Copper-64 dichloride or Copper chloride (64CuCl2).[1] This substance is not a treatment itself but a tool used to help doctors see what’s happening inside your body.

Medical Uses

COPPER (64CU) CHLORIDE is primarily used in a type of medical imaging called PET/CT (Positron Emission Tomography/Computed Tomography). This imaging technique is used for various purposes, including:

  • Diagnosing and monitoring Wilson’s Disease, a rare genetic disorder that causes copper to accumulate in the body[1]
  • Detecting and evaluating neuroendocrine neoplasms (NENs), which are tumors that can occur in various parts of the body, particularly in the digestive system and pancreas[2]

How It Works

When COPPER (64CU) CHLORIDE is injected into your body, it emits small amounts of radiation. Special cameras can detect this radiation and create detailed images of your internal organs and tissues. This helps doctors see areas where copper is accumulating or where certain types of tumors are present.

Administration

COPPER (64CU) CHLORIDE is given as an intravenous (IV) injection, which means it’s delivered directly into your bloodstream through a vein.[1][2] The amount given is carefully calculated based on your individual needs and the specific purpose of the imaging study.

Ongoing Research

Currently, there are clinical trials investigating the use of COPPER (64CU) CHLORIDE in different medical applications:

  1. A study is looking at its use in combination with a gene therapy called VTX-801 for treating Wilson’s Disease.[1]
  2. Another trial is exploring its use in combination with another imaging agent (18F-FDG) to predict outcomes in patients with neuroendocrine neoplasms.[2]

Eligibility for Clinical Trials

If you’re interested in participating in a clinical trial involving COPPER (64CU) CHLORIDE, eligibility criteria may include:

  • Age requirements (typically 18 years or older)
  • Specific medical conditions (such as Wilson’s Disease or neuroendocrine neoplasms)
  • Stable health status
  • No history of certain allergies or other medical conditions that might interfere with the study

It’s important to note that each clinical trial has its own specific eligibility criteria, which your doctor can discuss with you in detail.[1][2]

Potential Benefits

The use of COPPER (64CU) CHLORIDE in medical imaging may offer several potential benefits:

  • Improved diagnosis and monitoring of Wilson’s Disease
  • Better detection and evaluation of neuroendocrine tumors
  • Helping doctors predict how well a patient might respond to certain treatments
  • Assisting in planning more personalized treatment strategies

Safety Considerations

While COPPER (64CU) CHLORIDE is generally considered safe for diagnostic use, there are some important considerations:

  • It should not be used in patients with a history of allergic reactions to similar compounds
  • It may not be suitable for pregnant or breastfeeding women
  • There may be weight restrictions for the imaging equipment
  • Certain medical conditions (like uncontrolled diabetes or infections) may affect its use

As with any medical procedure, it’s essential to discuss all potential risks and benefits with your healthcare provider.[1][2]

Aspect Wilson’s Disease Trial Neuroendocrine Tumor Imaging Trial
Trial Phase Phase I/II Phase II
Main Objective Assess safety and tolerability of VTX-801 with Copper (64Cu) Chloride Develop models to predict progression-free survival using 64Cu-DOTATATE and 18F-FDG PET/CT scans
Patient Age Range 18-65 years 18 years and above
Key Inclusion Criteria Confirmed Wilson’s Disease diagnosis, stable for ≥1 year Verified gastro-pancreatic neuroendocrine neoplasm
Administration Route Intravenous Intravenous
Primary Endpoint Safety and tolerability profile Progression-free survival

Ongoing Clinical Trials on Copper (64Cu) Chloride

  • A study comparing different zinc doses for the treatment of Wilson disease in healthy participants.

    Recruiting

    2 1 1
    Denmark
  • Study of 64Cu-DOTATATE and 18F-FDG PET/CT imaging to predict disease progression in patients with neuroendocrine neoplasms

    Recruiting

    2 1 1 1
    Denmark
  • Evaluation of V-Cu64 versus V-Ga68 PET-CT imaging in adults with diagnosed or suspected neuroendocrine tumors

    Not yet recruiting

    3 1 1 1
    Poland
  • Comparing Copper (64Cu) Chloride PET/CT and Fluorocholine (18F) PET/CT for Detecting Metastasis in Prostate Cancer Patients at Risk

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    Italy
  • Study on Using Copper (64Cu) Chloride PET/CT Imaging for Prostate Cancer Patients with Biochemical Relapse After Surgery to Guide Radiation Therapy

    Not yet recruiting

    3 1 1
    Investigated drugs:
    Italy
  • Study on Gene Therapy with VTX-801 and Copper (64Cu) Chloride for Adults with Wilson’s Disease

    Not recruiting

    2 1 1
    Denmark Germany

Glossary

  • Wilson's Disease: A rare genetic disorder that causes copper to accumulate in the liver, brain, and other vital organs.
  • Neuroendocrine Tumors: Rare tumors that develop from cells of the neuroendocrine system, which is responsible for producing hormones.
  • Gene Therapy: A technique that uses genes to treat or prevent disease, often by replacing a faulty gene or introducing a new gene to help fight a disease.
  • PET/CT: Positron Emission Tomography/Computed Tomography, an imaging technique that combines PET and CT scans to provide detailed pictures of the body's structures and functions.
  • 64Cu-DOTATATE: A radioactive compound used in PET/CT imaging to detect and assess neuroendocrine tumors.
  • Intravenous (IV): A method of administering medication or fluids directly into a vein.
  • Pharmacodynamics: The study of how a drug affects the body, including its mechanism of action and the relationship between drug concentration and effect.
  • Progression-free Survival: The length of time during and after treatment that a patient lives with the disease but it does not get worse.
  • Overall Survival: The length of time from either the date of diagnosis or the start of treatment that patients are still alive.
  • Peptide Receptor Radionuclide Therapy: A targeted treatment for certain types of neuroendocrine tumors that uses radioactive substances attached to molecules that bind to tumor cells.

References

  1. http://clinicaltrials.eu/trial/study-on-gene-therapy-with-vtx-801-and-copper-64cu-chloride-for-adults-with-wilsons-disease/
  2. http://clinicaltrials.eu/trial/study-on-pet-ct-imaging-with-64cu-dotatate-and-18f-fdg-for-patients-with-neuroendocrine-tumors/